Simplex Trading’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,200
| Closed | -$108K | – | 11038 |
|
|
2022
Q3 | $108K | Buy |
7,200
+6,500
| +929% | +$75.6K | ﹤0.01% | 5423 |
|
|
2022
Q2 | $5K | Sell |
700
-1,400
| -67% | -$9.87K | ﹤0.01% | 8909 |
|
|
2022
Q1 | $19K | Buy |
2,100
+1,800
| +600% | +$13.9K | ﹤0.01% | 8330 |
|
|
2021
Q4 | $2K | Sell |
300
-1,000
| -77% | -$10.5K | ﹤0.01% | 10112 |
|
|
2021
Q3 | $21K | Hold |
1,300
| – | – | ﹤0.01% | 8428 |
|
|
2021
Q2 | $20K | Buy |
1,300
+1,241
| +2,103% | +$21.3K | ﹤0.01% | 8605 |
|
|
2021
Q1 | $105K | Sell |
59
-74
| -56% | -$1.28K | ﹤0.01% | 5691 |
|
|
2020
Q4 | $179K | Buy |
133
+107
| +412% | +$1.29K | ﹤0.01% | 4765 |
|
|
2020
Q3 | $30K | Buy |
26
+22
| +550% | +$268 | ﹤0.01% | 6084 |
|
|
2020
Q2 | $5K | Sell |
4
-158
| -98% | -$2.34K | ﹤0.01% | 7020 |
|
|
2020
Q1 | $218K | Sell |
162
-539
| -77% | -$10.2K | ﹤0.01% | 3494 |
|
|
2019
Q4 | $1.69M | Buy |
701
+130
| +23% | +$2.69K | ﹤0.01% | 1622 |
|
|
2019
Q3 | $1.1M | Buy |
571
+549
| +2,495% | +$12.6K | ﹤0.01% | 1849 |
|
|
2019
Q2 | $65K | Sell |
22
-125
| -85% | -$4.82K | ﹤0.01% | 4627 |
|
|
2019
Q1 | $698K | Sell |
147
-552
| -79% | -$24.3K | ﹤0.01% | 2307 |
|
|
2018
Q4 | $2.52M | Buy |
699
+686
| +5,277% | +$32.2K | 0.01% | 941 |
|
|
2018
Q3 | $80K | Sell |
13
-24
| -65% | -$1.54K | ﹤0.01% | 4683 |
|
|
2018
Q2 | $249K | Sell |
37
-32
| -46% | -$1.79K | ﹤0.01% | 3230 |
|
|
2018
Q1 | $14K | Sell |
69
-356
| -84% | -$19.9K | ﹤0.01% | 3730 |
|
|
2017
Q4 | $83K | Sell |
425
-19
| -4% | -$1.15K | ﹤0.01% | 1958 |
|
|
2017
Q3 | $61K | Buy |
444
+368
| +484% | +$20.1K | ﹤0.01% | 2135 |
|
|
2017
Q2 | $21K | Buy |
76
+13
| +21% | +$605 | ﹤0.01% | 3274 |
|
|
2017
Q1 | $7K | Sell |
63
-110
| -64% | -$4.91K | ﹤0.01% | 4354 |
|
|
2016
Q4 | $65K | Sell |
173
-247
| -59% | -$9.34K | ﹤0.01% | 1908 |
|
|
2016
Q3 | $312K | Buy |
420
+272
| +184% | +$6K | 0.02% | 751 |
|
|
2016
Q2 | $55K | Buy |
148
+109
| +279% | +$1.76K | ﹤0.01% | 1966 |
|
|
2016
Q1 | $1K | Buy |
39
+31
| +388% | +$490 | ﹤0.01% | 5297 |
|
|
2015
Q4 | $1K | Sell |
8
-207
| -96% | -$4.83K | ﹤0.01% | 5070 |
|
|
2015
Q3 | $18K | Sell |
215
-21
| -9% | -$380 | ﹤0.01% | 2928 |
|
|
2015
Q2 | $18K | Buy |
236
+187
| +382% | +$3.43K | ﹤0.01% | 2578 |
|
|
2015
Q1 | $22K | Buy |
+49
| New | +$1.42K | ﹤0.01% | 2275 |
|
Simplex Trading's AERI Position: Q4 2022 in Review
Simplex Trading sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 4,120 shares — an estimated $62K sold.
Simplex Trading first reported a position in AERI in Q2 2015 and held it in 23 quarters. The position peaked at $1.33M in Q3 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Simplex Trading reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Simplex Trading sold 4,120 Aerie Pharmaceuticals shares in Q4 2022, an estimated $62K.
- Simplex Trading first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 23 quarters.
- Simplex Trading's Aerie Pharmaceuticals position peaked at $1.33M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.